The role of complement and complement therapeutics in patients with NMSOD and MG – Earn CME credits with this activity
Earn CME credits with this activity “Complement directed therapies for NMOSD and myasthenia gravis fortunately exist and we can…
MS Symposium Alabama – Featured Topics: Biosimilars, Bladder Issues, Physical Therapy, MS/relationships and MS Symptoms Management, Treatments and more – plus NMOSD
Watch this (5) Speaker (Presenter) educational program featuring topics on Biosimilars, Bladder Issues, Physical Therapy, MS/relationships and MS Symptoms Management,…
Stuart Schlossman
Biomarker found for potential new disorder that Has-Been labeled as MS (Learning more about #NMOSD, #MOG and #MOGAD)
Findings could pave way for more targeted treatments, researchers say by Marisa Wexler, MS | August 11, 2023 An antibody…
Stuart Schlossman
Study Suggests Breast Cancer Screening for Elderly Patients With New-Onset NMOSD
Leonardo Jaimes, MD | Publish Date: August 2, 2023 Paraneoplastic syndromes associated with breast cancer can present with neuromyelitis optica spectrum…
Stuart Schlossman
Researchers Present An Atypical Case of NMOSD
Ozge Ozkaya, MSc, PhD | Publish Date July 28, 2023 A team of researchers from the United States presented the…
Stuart Schlossman
Clinical features of MOGAD with brainstem involvement in the initial attack versus NMOSD and MS – PubMed
This is a PubMed Article: https://pubmed.ncbi.nlm.nih.gov/37402345/ Qiao Xu 1, Xixi Yang 1, Zhandong Qiu 1, Dawei Li 1, Hongxing Wang 1, Hong Ye 1, Lidong Jiao 1, Jing Zhang 1, Li Di 1, Peng Lei 2, Huiqing Dong 1, Zheng Liu 3 Affiliations expand PMID: 37402345…
Stuart Schlossman
Patients With NMOSD ( neuromyelitis optica spectrum disorder ) Relapse Events Experience High Economic Burden
#ACTRIMS #NMOSD Feb 27, 2023 Isabella Ciccone, MPH A…
Stuart Schlossman
Living with Neuromyelitis Optical Spectrum Disorder (NMOSD) – A Patient’s story
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Stuart Schlossman
Latest updates for diagnosis and management of NMOSD
In this enduring touchSATELLITE SYMPOSIUM (#ACTRIMS22), Prof. Sean Pittock, Dr Amy Kunchok, and Prof. Dean Wingerchuk share their insights…
Stuart Schlossman
Serum GFA Identified as a Biomarker for NMOSD, sNfL as a Predictor of Poor Post-Attack Outcomes
March 12, 2022 A systematic literature review of randomized controlled trials in neuromyelitis optica spectrum disorder was performed, with 7…
Stuart Schlossman
